Fungal Testing Kits Market Outlook

The fungal testing kits market poised to increase exponentially, surpassing US$ 4504 million by 2033, from a predicted market size of US$ 1.72 billion in 2023.

The ensuing fungal testing kits market propulsion is due to increased acceptance of point-of-care diagnostics, the emergence of nano sensor detection based kits and fungal identification by molecular tools.

FMI presented a comparative analysis of market growth rates and development possibilities in the global fungal testing equipment market. Device restrictions, illness epidemiology, and the rate of product uptake all have an impact on the market, as do macroeconomic and industrial factors.

The creation of low-cost kits, as well as increased attempts to raise awareness of fungal diseases, is a significant step towards strengthening fungal testing kits industry.

Attributes Details
Fungal Testing Kits Market HCAGR (From 2018 to 2022) 8.6%
Fungal Testing Kits Market CAGR (From 2023 to 2033) 10.1%
Fungal Testing Kits Market Size (2022) US$ 1558 million
Fungal Testing Kits Market Size (2023) US$ 1716.5 million
Fungal Testing Kits Market Size (2033) US$ 4504.0 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Fungal Testing Kit Sales Analysis from 2018 to 2022 Compared to the Market Outlook from 2023 to 2033

From 2018 to 2022, the fungal testing equipment market grew at a CAGR of 8.6%, reaching US$ 1558 million in that year.

One of the few significant gynaecological issues affecting women of reproductive age is the rising occurrence of fungal illnesses such vaginitis. Vaginitis is becoming more common as a result of changing lifestyles, acquiring bad habits including smoking, and unprotected sexual activity.

These elements contribute to the increased demand for fungus testing kits on a global scale, particularly given the slow growth of anti-fungal studies and product development breakthroughs. The development of fungal testing kits for a variety of illness indications has been fueled by rising regional government financing initiatives for disease diagnosis and medical testing kit development.

Pharmaceutical companies are investing more in research to create novel antifungal diagnostics and treatments, and the key manufacturers are concentrating on teaming up with academic institutions or research institutes to create unique products.

Several potential treatments for fungi infections have also been investigated by researchers, including the use of bacteriophages and antifungal peptides. These methods are currently being developed, albeit they have not yet been successfully incorporated into medical products. In addition, it is anticipated that the prevalence of fungal diseases, which are brought on by the presence of fungus or mould, may increase.

A significant element that may spur fungal testing equipment market expansion is the commercial availability of enhanced diagnostic testing for fungi illnesses.

Profound Motivators

  • Increasing elderly population and susceptibility to fungal infections has seen enormous multiplication, resulting in an amazing long-term increase in the market.
  • As the prevalence of various fungal illnesses rises and the commercial availability of diagnostic tests expands, the fungal testing equipment market may likely expand to greater echelons.

Health-Related Awareness Campaigns Encourage Use of Testing Facilities Boosting Income

Healthcare providers and health organizations have launched a numerous awareness campaigns, including online education programs for the general public and medical professionals around the world as well as environmental campaigns, medication maintenance campaigns, and campaigns focusing on specific viral and fungus diseases.

These initiatives promote the use of testing facilities, which is likely to increase revenue for the global fungus test kits market during the course of the projected period.

People now live longer thanks to improvements in diagnostic and treatment costs brought about by changes in healthcare systems in many nations, including the USA and Japan.

In light of the high frequency of viral and fungal illnesses, rising life expectancy is another important driver projected to drive growth in the global fungal test kits market. The elderly population is more prone to fungal diseases or the risk of fungal disease is increased.

The fungal testing equipment market to expand at a significant rate, with a CAGR of close to 10.1%. The aforementioned reasons contribute to the fungus testing kits market sales forecast and add value to the entire healthcare sector.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

The Pertinent Opportunity for Fungal Testing Kit Manufacturers

In comparison to North America and Europe, the fungal testing kits sector is growing rapidly in various Asian countries, including Japan, India, and China. This is mostly owing to the existence of a significant patient (asthmatic) population in these areas, including youngsters and the elderly.

The sector is experiencing opportunistic expansion in the collaborative market space and is participating in the fungal testing kits market, with a greater emphasis on investing in Asia Pacific growing nations.

Due to increased healthcare expenditures and the presence of a big patient pool suffering from various fungal diseases such as candida and IFD, these countries provide a tremendous potential for various healthcare devices.

The development of PCR techniques has enabled scientists to find novel genes, gene expression, and genetic variation in an organism's tissues, allowing them to control the comparative analysis of illnesses and normal tissues, which raises demand for fungal testing kits.

Real-time PCR techniques are commonly utilized in research laboratories to detect the existence of mutant genes or the quantitative level of gene copy number in transformed cell lines.

  • Omron Healthcare, Inc. established a subsidiary in South Korea in January 2013 to offer medical products for personal and professional usage.

Focusing on these developing markets is therefore projected to help creators and suppliers of fungal testing kits achieve significant revenue and market share growth. Growing healthcare research and development spending and the adoption of molecular diagnostic testing provide remunerative opportunities for the growth of the fungal test kits market.

Constraints on Demand for Fungal Testing Kits

In low- and middle-income countries in particular, the low level of social acceptability of infections has resulted in patients seeking care from office-based healthcare facilities that make the claim to be able to treat the condition naturally using conventional drugs.

Sexually transmitted diseases and genital diseases are spread significantly by these societal variables. Unemployment, poverty, and social injustice are a few of the significant, widespread issues that are contributing factors in the fungal testing equipment market.

The treatment of genital disease is hampered by a lack of openness and diversity in sexual communication, and the population of those who are underserved who have STDs grows.

Sexually active women frequently experience vaginitis. In social networks like sex workers, where high-risk health behaviors are predominant, vaginitis disproportionately impacts excluded groups and people who belong to those networks. Sexually transmitted diseases pose a serious threat to both sex workers and the people they provide services to. Due to this social burden, dishonest practices and claims of expertise in the treatment of genital and sexually transmitted illnesses have increased.

Despite its affordability and accuracy in the diagnosis of viral infections, the limitations of PCR are a crucial factor to take into account. Real-time PCR requires more time to run (2–5 hours) than other procedures, and there is a significant danger of contamination while handling, particularly during the specimen preparation step.

Another downside of immunoassays in the fungal test kits market is the high expense of supplies and equipment, especially in environments with limited resources. This is because automated techniques tend to be more precise and sensitive.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of Adjacent Fungal Testing Kits Market 

Fungal Testing Kits Market:

Attributes Fungal Testing Kits Market
CAGR (From 2023 to 2033) 10.1%
Market Value (2023) US$ 1716.5 million
Growth Factor Aged individuals are quite susceptible to fungus infections. This element has contributed to the market's growth.
Opportunity Governments are making more investments in the production of fungus diagnostic kits. This may have a favourable impact on market expansion.
Key Trends Increased population means a higher likelihood of illnesses spreading. This can spur market expansion.

Rapid Medical Diagnostic Kits Market:

Attributes Rapid Medical Diagnostic Kits Market
CAGR (From 2023 to 2033) 3.4%
Market Value (2023) US$ 15.26 billion
Growth Factor Due to the growing need for and knowledge of rapid medical evaluation of chronic disorders, the industry to pick up steam.
Opportunity Due to the rise in multidrug resistant bacterial diseases, there is going to be an increased demand for urgent medical assessment.
Key Trends The demand for quick medical supplies is rising as a result of changing environmental conditions and expanding populations, which is promoting market growth.

Sepsis Diagnostics Market:

Attributes Sepsis Diagnostics Market
CAGR (From 2023 to 2033) 9.6%
Market Value (2023) US$ 739.23 million
Growth Factor Sepsis is very common, and as awareness grows, it may considerably fuel market growth.
Opportunity Market expansion is being facilitated by rising regulatory approval rates and the introduction of technologically sophisticated diagnostic technologies.
Key Trends The release of increasingly sophisticated diagnostic solutions to support market expansion.

Segmentation Outlook

Which Fungal Test Kits Test Type Has Had Been Leading Market Growth?

Segment Details
Top Test Type Molecular Test
CAGR % 2017 to 2022 6.6%
CAGR % 2023 to End of Forecast(2033) 7.5%

By 2023, molecular testing expects to have a market share of over 31.5% and to have experienced profitable growth at a CAGR of 7.5%. The molecular tests, unlike conventional testing techniques, only identify the chemicals that are indicative of the presence of the organism and do not identify the living organisms linked to the disease indication.

This guarantees accurate pathogen diagnosis and subsequent treatment, supporting the global market expansion for fungal testing kits.

Which End User is Noteworthy in the Global Market?

Segment Details
Top End User Diagnostic Laboratory
CAGR % 2017 to 2022 7.2%
CAGR % 2023 to End of Forecast(2033) 7.4%

The estimation for the fungal test kits market share held by diagnostic laboratories over the predicted period is 42.4%.

The diagnostic laboratories hold a sizeable global market share for fungal testing kits due to the accessibility of mobile test kit units in point-of-care diagnostic settings, and they are anticipated to maintain stable growth throughout the course of the forecast period.

Which Sample Type is contributing to the Market Growth for Fungal Testing Kits?

Segment Details
Segment Share 36.1%
Segment CAGR 12.6%

With a market share of more than 36.1% in 2023, Skin anticipates a lucrative increase at a CAGR of 12.6% until the conclusion of the projected period. The majority of people who are susceptible to fungal-related illnesses have yeast infections and superficial skin diseases.

Consequently, using a sample of the patient's skin can reveal the type of pathogen causing the ailment and help with therapy, which is what is driving the fungus testing kits market.

Which Application Can Fuel the Growth of the Fungal Testing Equipment Market?

Segment Details
Segment Share 67.3%
Segment CAGR 11%

Medical Diagnosis anticipates a profitable growth rate of 11.0% until the conclusion of the projected period, with a fungal test kits market share of more than 67.3% in 2023. The precise assessment of disease features in the diagnosis of fungal infections is a crucial part of disease organism elimination or control.

Medical diagnosis and tests are designed to provide precise insights into patients' infections and disorders, as well as accurate identification of the pathogen in question, resulting in better clinical outcomes.

Regional Outlook

Country United States
HCAGR (2018 to 2022) 8.3%
CAGR (2023 to 2033) 9.8%
Country China
HCAGR (2018 to 2022) 11.1%
CAGR (2023 to 2033) 12.9%
Country Canada
HCAGR (2018 to 2022) 8.0%
CAGR (2023 to 2033) 8.4%
Country Germany
HCAGR (2018 to 2022) 9.2%
CAGR (2023 to 2033) 12.6%
Country United Kingdom
HCAGR (2018 to 2022) 9.5%
CAGR (2023 to 2033) 9.8%

What Creates the United States a Prominent Market?

Attributes Details
United States Market Size (US$ million) by End of Forecast Period (2033) US$ 1210.95 million
United States Market Absolute Dollar Growth (US$ million) US$ 51.7 million

With a CAGR of 9.8%, the United States currently dominates the North American area, and it is anticipated that it may maintain its rapid growth during the forecast period. Due to the high prevalence of infectious diseases and the rapid advancements in diagnostic procedures, the nation has a sizable market share in the North American continent.

Throughout the anticipated time frame, the fungal test kits market to rise at a profitable rate owing to the essential presence of point-of-care diagnostics and education initiatives about infection prevention and control.

What Makes China a Hotspot for Fungal Testing Kits?

Attributes Details
China Market Size (US$ million) by End of Forecast Period (2033) US$ 488.22 million
China Market Absolute Dollar Growth (US$ million) US$ 20.7 million

China is expected to represent 51.3% of the East Asia market in 2023, with a CAGR of 12.9% during the forecast period. The region of East Asia has an edge in terms of sales growth potential of fungal testing kits, attributable to a booming patient pool as well as the consequent expanding healthcare expenditure by the government agencies.

According to a national assessment on fungal infection diagnostic capacity in China, the overall testing capacity for fungal infections in China is limited, posing a significant opportunity for the country's fungal testing kits market to grow throughout the projection period.

Why is the Demand for Fungus Testing Kits Soaring in Canada?

Attributes Details
Canada Market Size (US$ million) by End of Forecast Period (2033) US$ 105.55 million
Canada Market Absolute Dollar Growth (US$ million) US$ 4.00 million

Canadian market is escalating at a robust CAGR of 8.4% from 2023 to 2033 and attaining US$ 105.55 million by 2033.

In the North America area, Canada has grown into the second leading force in the fungal testing equipment market after the United States. This is due to the widespread incidence of infectious diseases. As knowledge of numerous fungal infections has grown in this region, the demand for fungal testing kits has increased.

Why is Germany Seen as a Lucrative Market in Europe for Fungus Testing Kits?

Attributes Details
Germany Market Size (US$ million) by End of Forecast Period (2033) US$ 352.17 million
Germany Market Absolute Dollar Growth (US$ million) US$ 12.6 million

Germany is to experience a CAGR of roughly 12.6% in the European fungal testing kits market over the anticipated period. The established regulatory presence of medical and diagnostic items in the European region positions a higher presence of fungal testing kits in the nation.

A push into the sales of fungus testing kits in the nation has been further begun with the approval of such items and the existence of a CE mark. Furthermore, the region now presents a profitable value in terms of sales in Germany thanks to educational initiatives and awareness efforts.

Why Do Fungal Testing Kit Suppliers See the United Kingdom as a Key Market?

Attributes Details
United Kingdom Market Size (US$ million) by End of Forecast Period (2033) US$ 250.61 million
United Kingdom Market Absolute Dollar Growth (US$ million) US$ 10.7 million

The United Kingdom market has the potential to approach US$ 250.61 million by 2033, with a CAGR of 19.8% from 2021 to 2031.

In light of the rising prevalence of cancer, rising fungal test kits manufacturers’ actions, and rising government initiatives, the usage of infectious disease diagnostics kits, assays, and other consumables has expanded.

The expanding usage of infectious disease diagnostics kits, tubes, and reagents among major end users, as well as increasing investments by healthcare businesses to meet industry demand, are likely to fuel fungal test kits market expansion.

What is the Future of Fungal Testing Kits in India?

Attributes Details
India Market CAGR 14.5%
Indian Market Share 54.6%

In 2023, India held a 54.6% share in the South Asia fungal testing kits market, and is predicted to develop at a CAGR of 14.5% from 2023 to 2033. The pandemic caused a continuous increase in fungal diseases across India.

Medical diagnostic kit sales in the country increased with the help of internationally recognised players such as Abbott. Rising fungal testing kits sales to continue in the country, along with healthcare initiatives to ensure excellent patient outcomes.

How Competition Influences the Fungal Testing Kits Market? 

In addition to focusing on research and development, leading fungal testing kits manufacturers prioritise the creation of new product lines with novel applications. To maintain their market presence, the leading firms also engage in mergers and acquisitions.

Recent Development

Date March 2020
Company BioMérieux
Details The SARS-COV-2 R-GENE® test was developed by BioMérieux. The French Reference Center for Respiratory Infectious Diseases validated this real-time PCR test running on open platforms, showing its remarkable performance. It is manufactured and sold in France, and it is expected to be CE-marked and submitted to the FDA for a EUA (Emergency Use Authorization) soon. BioMérieux is also working on an improved version of their BIOFIRE® FILMARRAY® Respiratory Panel 2, dubbed the BIOFIRE® Respiratory Panel 2.1. (RP2.1). This new panel can include SARS-CoV-2 as well as 21 other prevalent respiratory viruses and can provide results in about 45 minutes. It can also be offered on the platforms FILMARRAY® 2.0 and FILMARRAY® TORCH.
Date July 14, 2021
Company ELITech Group
Details Gonotec GmbH, a medical products company, was bought by ELITech Group.

Key Players

  • Biomed Diagnostics, Inc.
  • Bioquochem
  • C.P.M. Diagnostic Research SAS
  • ELITech Group
  • ADT Biotech
  • Cole-Parmer India Pvt. Ltd.
  • PerkinElmer
  • GenMark Diagnostics, Inc.
  • Norgen Biotek
  • PCRmax
  • Merck KGaA
  • Thermofisher Scientfic

Key Segments

By Test Type:

  • Molecular Test
  • Chromogenic Test
  • Others

By Sample Type:

  • Skin
  • Urine
  • Vaginal secretions
  • Blood
  • Cerebral
  • Others

By Application:

  • Research
  • Susceptibility Testing
  • Medical Diagnosis
  • Others

By End User:

  • Diagnostic Laboratory
  • Hospitals
  • Pharmaceutical Companies
  • Research and Academic Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

What is the size of the global Fungal Testing Kits Industry in 2023?

The global industry is expected to reach a valuation of US$ 1716.5 million in 2023.

Who are Industry?

the leading players in the Biomed Diagnostics, Inc., Bioquochem and C.P.M. Diagnostic Research SAS are the leading the industry players.

What will be the Fungal Testing Kits market value in 2033?

The fungal testing kits industry is likely to reach a valuation of US$ 4504.0 million by 2033.

What are the major factors driving the Sales of the Fungal Testing Kits Market?

Growing adoption of point-of-care diagnostics will drive industry sales.

Which is the key test type segment in the Fungal Testing Kits market through 2033?

The molecular test segment to remain preferred test type through 2033.

Table of Content

1. Executive Summary | Fungal Testing Kits Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033

        5.3.1. Molecular Test

        5.3.2. Chromogenic Test

        5.3.3. Others

    5.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sample Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Sample Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033

        6.3.1. Skin

        6.3.2. Urine

        6.3.3. Vaginal secretions

        6.3.4. Blood

        6.3.5. Cerebral

        6.3.6. Others

    6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Sample Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033

        7.3.1. Research

        7.3.2. Susceptibility Testing

        7.3.3. Medical Diagnosis

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By Application , 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Diagnostic Laboratory

        8.3.2. Hospitals

        8.3.3. Pharmaceutical Companies

        8.3.4. Research and Academic Institutes

    8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. South Asia

        9.3.5. East Asia

        9.3.6. Oceania

        9.3.7. MEA

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Test Type

        10.2.3. By Sample Type

        10.2.4. By Application

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Test Type

        10.3.3. By Sample Type

        10.3.4. By Application

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Test Type

        11.2.3. By Sample Type

        11.2.4. By Application

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Test Type

        11.3.3. By Sample Type

        11.3.4. By Application

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. United kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Test Type

        12.2.3. By Sample Type

        12.2.4. By Application

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Test Type

        12.3.3. By Sample Type

        12.3.4. By Application

        12.3.5. By End User

    12.4. Key Takeaways

13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Malaysia

            13.2.1.3. Singapore

            13.2.1.4. Thailand

            13.2.1.5. Rest of South Asia

        13.2.2. By Test Type

        13.2.3. By Sample Type

        13.2.4. By Application

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Test Type

        13.3.3. By Sample Type

        13.3.4. By Application

        13.3.5. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Test Type

        14.2.3. By Sample Type

        14.2.4. By Application

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Test Type

        14.3.3. By Sample Type

        14.3.4. By Application

        14.3.5. By End User

    14.4. Key Takeaways

15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. Australia

            15.2.1.2. New Zealand

        15.2.2. By Test Type

        15.2.3. By Sample Type

        15.2.4. By Application

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Test Type

        15.3.3. By Sample Type

        15.3.4. By Application

        15.3.5. By End User

    15.4. Key Takeaways

16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Test Type

        16.2.3. By Sample Type

        16.2.4. By Application

        16.2.5. By End User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Test Type

        16.3.3. By Sample Type

        16.3.4. By Application

        16.3.5. By End User

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Test Type

            17.1.2.2. By Sample Type

            17.1.2.3. By Application

            17.1.2.4. By End User

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Test Type

            17.2.2.2. By Sample Type

            17.2.2.3. By Application

            17.2.2.4. By End User

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Test Type

            17.3.2.2. By Sample Type

            17.3.2.3. By Application

            17.3.2.4. By End User

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Test Type

            17.4.2.2. By Sample Type

            17.4.2.3. By Application

            17.4.2.4. By End User

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Test Type

            17.5.2.2. By Sample Type

            17.5.2.3. By Application

            17.5.2.4. By End User

    17.6. United kingdom

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Test Type

            17.6.2.2. By Sample Type

            17.6.2.3. By Application

            17.6.2.4. By End User

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Test Type

            17.7.2.2. By Sample Type

            17.7.2.3. By Application

            17.7.2.4. By End User

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Test Type

            17.8.2.2. By Sample Type

            17.8.2.3. By Application

            17.8.2.4. By End User

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Test Type

            17.9.2.2. By Sample Type

            17.9.2.3. By Application

            17.9.2.4. By End User

    17.10. India

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Test Type

            17.10.2.2. By Sample Type

            17.10.2.3. By Application

            17.10.2.4. By End User

    17.11. Malaysia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Test Type

            17.11.2.2. By Sample Type

            17.11.2.3. By Application

            17.11.2.4. By End User

    17.12. Singapore

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Test Type

            17.12.2.2. By Sample Type

            17.12.2.3. By Application

            17.12.2.4. By End User

    17.13. Thailand

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Test Type

            17.13.2.2. By Sample Type

            17.13.2.3. By Application

            17.13.2.4. By End User

    17.14. China

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Test Type

            17.14.2.2. By Sample Type

            17.14.2.3. By Application

            17.14.2.4. By End User

    17.15. Japan

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Test Type

            17.15.2.2. By Sample Type

            17.15.2.3. By Application

            17.15.2.4. By End User

    17.16. South Korea

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Test Type

            17.16.2.2. By Sample Type

            17.16.2.3. By Application

            17.16.2.4. By End User

    17.17. Australia

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Test Type

            17.17.2.2. By Sample Type

            17.17.2.3. By Application

            17.17.2.4. By End User

    17.18. New Zealand

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Test Type

            17.18.2.2. By Sample Type

            17.18.2.3. By Application

            17.18.2.4. By End User

    17.19. GCC Countries

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Test Type

            17.19.2.2. By Sample Type

            17.19.2.3. By Application

            17.19.2.4. By End User

    17.20. South Africa

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Test Type

            17.20.2.2. By Sample Type

            17.20.2.3. By Application

            17.20.2.4. By End User

    17.21. Israel

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Test Type

            17.21.2.2. By Sample Type

            17.21.2.3. By Application

            17.21.2.4. By End User

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Test Type

        18.3.3. By Sample Type

        18.3.4. By Application

        18.3.5. By End User

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Biomed Diagnostics, Inc.

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. Bioquochem

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. C.P.M. Diagnostic Research SAS

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. ELITech Group

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. ADT Biotech

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. Cole-Parmer India Pvt. Ltd.

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. PerkinElmer

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. GenMark Diagnostics, Inc.

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Norgen Biotek

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. PCRmax

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

        19.1.11. Merck KGaA

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. Profitability by Market Segments

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

        19.1.12. Thermofisher Scientfic

            19.1.12.1. Overview

            19.1.12.2. Product Portfolio

            19.1.12.3. Profitability by Market Segments

            19.1.12.4. Sales Footprint

            19.1.12.5. Strategy Overview

                19.1.12.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Fungal Keratitis Treatment Market

June 2018

REP-GB-6934

August 2023

249 pages

Healthcare

Fungal Staining Reagent Market

September 2024

REP-GB-13707

Upcoming

Explore Healthcare Insights

View Reports
Future Market Insights

Fungal Testing Kits Market